ReviewCurrent urology reports2025
Digital Pathology Allows for Global Second Opinions for Urologic Malignancies.
Review in Current urology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewDigital pathology, the use of digital images for histopathologic diagnosis, is transforming the practice of pathology. This review discusses the ability of digital pathology to assist with second opinions for challenging cases in genitourinary pathology worldwide. RECENT
findingsWhile traditional pathology is limited by physical hardware such as microscopes and glass slides, digital pathology creates opportunities for the rapid sharing of diagnostic materials with colleagues and experts worldwide. This technology can greatly facilitate sharing challenging cases from low-resource areas where pathology services or subspecialty expertise are not available. As the incidence of kidney, prostate, and testicular cancer continues to increase in both high-income and developing countries, digital pathology may be the solution for expert opinions in diagnosing urologic disease worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.